Publications by authors named "Anja Riediger"

Claim this Profile
D
Digital twins for personalized treatment in uro-oncology in the era of artificial intelligence.
Magdalena Görtz, Carlos Brandl, Anna Nitschke, Anja Riediger, Daniel Stromer

Nat Rev Urol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital spatial profiling identifies phospho-JNK as a biomarker for early risk stratification of aggressive prostate cancer.
Samaneh Eickelschulte, Adam Kaczorowski, Florian Janke, Anja Lisa Riediger, Olga Lazareva

Front Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative analysis of blood biomarkers and clinical variables improves early detection of aggressive prostate cancer.
Olga Lazareva, Anja Riediger, Oliver Stegle, Holger Sültmann, Markus Hohenfellner

Sci Rep· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-coverage whole genome sequencing of cell-free DNA to predict and track immunotherapy response in advanced non-small cell lung cancer.
Florian Janke, Mateo Gasser, Arlou K Angeles, Anja L Riediger, Magdalena Görtz

J Exp Clin Cancer Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early circulating tumor DNA changes predict outcomes in head and neck cancer patients under re-radiotherapy.
Florian Janke, Florian Stritzke, Katharina Dvornikovich, Henrik Franke, Arlou Kristina Angeles, Anja Lisa Riediger

Int J Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prostate cancer detection through unbiased capture of methylated cell-free DNA.
Ermira Lleshi, Toby Milne-Clark, Henson Lee Yu, Henno W Martin, Robert Hanson, Anja Lisa Riediger

iScience· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal monitoring of cell-free DNA methylation in ALK-positive non-small cell lung cancer patients.
Florian Janke, Arlou Kristina Angeles, Anja Lisa Riediger, Simone Bauer, Martin Reck

Clin Epigenetics· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer.
Samaneh Eickelschulte, Anja Lisa Riediger, Arlou Kristina Angeles, Florian Janke, Stefan Duensing

Cancers (Basel)· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid Biopsies beyond Mutation Calling: Genomic and Epigenomic Features of Cell-Free DNA in Cancer.
Arlou Kristina Angeles, Florian Janke, Simone Bauer, Petros Christopoulos, Anja Lisa Riediger

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
Christopher G Smith, Tina Moser, Florent Mouliere, Johanna Field-Rayner, Matthew Eldridge, Anja L Riediger

Genome Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
Anna-Lena Volckmar, Holger Sültmann, Anja Riediger, Thoas Fioretos, Peter Schirmacher

Genes Chromosomes Cancer· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-specific molecular alterations are associated with metastatic clear cell renal cell cancer progressing under tyrosine kinase inhibitor therapy.
Steffen Dietz, Holger Sültmann, YueJun Du, Eva Reisinger, Anja Lisa Riediger

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients.
Anja Lisa Riediger, Steffen Dietz, Uwe Schirmer, Michael Meister, Ingrid Heinzmann-Groth

Sci Rep· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis